期刊文献+

阿霉素对Tca8113细胞端粒酶活性及端粒结合蛋白表达的影响 被引量:2

The effects of Adramycin on telomerase activity and expression of telomere repeat binding factor proteins in Tca8113 cells
原文传递
导出
摘要 目的观察阿霉素诱导Tca8113细胞凋亡对端粒酶活性及端粒结合蛋白(TRF)表达的影响;探讨端粒酶和TRF在细胞凋亡途径中的作用机制。方法通过Tca8113细胞MTT实验,确定后续实验中阿霉素作用浓度。将Tca8113培养细胞分成用药组和对照组,培养5d和7d后,利用流式细胞仪检测细胞凋亡;采用Giemsa染色进行凋亡形态学观察;通过端粒酶酶联免疫吸附实验对端粒酶活性进行定性和定量分析;利用免疫组化和免疫荧光标记法分别检测TRF表达和表达水平。结果5μg/ml阿霉素作为后续研究的作用浓度。在5μg/ml阿霉素作用5d和7d后,用药组细胞凋亡率分别为(36.4±1.7)%和(54.2±2.1)%,与对照组比较差异有统计学意义(P<0.05);Giemsa染色显示用药组出现明显凋亡细胞;TRAP检测结果表明,用药组端粒酶活性降低,与对照组比较,差异有统计学意义(P<0.05);端粒酶活性随阿霉素作用时间延长而降低(P<0.05);用药组与对照组细胞均有TRF表达,在细胞核内呈均匀蓝染状态,而在诱导凋亡细胞核和凋亡小体内呈点状弥散分布,但两组间TRF表达水平差异无统计学意义(P>0.05)。结论阿霉素诱导Tca8113细胞凋亡使其细胞内端粒酶活性受抑制,TRF表达特点发生改变,但未改变TRF表达水平。 Objective To observe the effects of apoptosis of Tca8113 cells induced by Adramycin on the telomerase activity and expression of telomere repeat binding factors (TRF) and probe the mechanism by which telomerase and TRF proteins function during transmitting apoptotic signals. Methods The effective concentration of Adramycin in the following experiments was determined by using methyhhiazolyl tetrazolium (MTT) assay of Tca8113 cells. Tca8113 cells cultured in the medium were divided into two experiment groups, namely treated group containing Adramycin and untreated one containing sodium saline. After cultured for 5 days and 7 days, apoptosis of Tca8113 cells was examined by flow cytometer method; apoptotic morphology after Giemsa staining was observed under microscope; a qualitative and quantitative analysis of telomerase activity was performed by TRAP (telomeric repeats amplification protocol)-enzyme-linked immunosorbent assay; expression and expression level of TRF proteins from Tca8113 cells were detected with immunohistochemical staining and immunofluorescence label assay respectively. Results The effective concentration of Adramycin in the subsequent experiments was determined as 5 μg/ml by MTT assay. After 5 days' and 7 days' treatment with Adramycin at 5 μg/ml, apoptotic rates of the treated groups were 36.42±1.70% and 54.24±2.07%, respectively, which were significantly different from those of the untreated groups (P 〈0.05); apoptotic cells obviously appeared in the treated groups after Giemsa staining; the immunosorbent assay indicated that telomerase activity from the treated groups dropped obviously, which was statistically significant compared with that from the untreated groups (P 〈 0.05); the activity level decreased with increasing duration of Adramycin at 5 μg/ml (P 〈 0.05 ); expression of TRF proteins which evenly appeared in the nucleus in blue were found in the cells of the two experiment groups; the expression in the plasma and apoptotic debris of induced apoptotic cells was characteristic of blue speckles distributed diffusely; there were no statistically difference on the expression level between the treated and untreated group (P 〉 0.05). Conclusions Inducing TcaSll3 cells apoptosis by Adramycin inhibited the telomerase activity, changed the expressive characteristics of TRF, but had no influence on the expression level of TRF proteins.
出处 《中华口腔医学研究杂志(电子版)》 CAS 2008年第2期14-18,共5页 Chinese Journal of Stomatological Research(Electronic Edition)
基金 中国博士后基金(中博基2003033421) 广东省医学科研基金(A2006237)
关键词 阿霉素 TCA8113细胞 凋亡 端粒酶 端粒结合蛋白 Adramycin Tca8113 cells Apoptosis Telomerase Telomere repeat bindingfactor
  • 相关文献

参考文献4

二级参考文献47

  • 1代晓明,李龙江,温玉明,王昌美,刘华,刘坤,李胜富.端粒酶催化亚单位转染血管内皮细胞的实验研究[J].华西口腔医学杂志,2004,22(5):373-375. 被引量:3
  • 2[1]Kelland LR.Telomerase inhibitors: targeting the vulnerable end of cancer[J]? Anticancer Drugs,2000,11(7):503-513.
  • 3[2]Kiyozuka Y,Yamamoto D,Yang J,Uemura Y,Senzaki H,Adachi S,et al.Correlation of chemosensitivity to anticancer drugs and telomere length,telomerase activity and telomerase RNA expression in human ovarian cancer cells[J].Anticancer Res,2000,20(1A):203-212.
  • 4[3]Faraoni I,Graziani G,Turriziani M,Masci G,Mezzetti J,Testori A,et al.Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples[J].Lab Invest,1999,79(8):993-1005.
  • 5[4]Faraoni I,Turriziani M,Masci G,De Vecchis L,Shay JW,Bonmassar E,et al.Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro[J].Clin Cancer Res,1997,3(4):579-585.
  • 6[5]Burger AM,Double JA,Newell DR.Inhibition of telom- erase activity by cisplatin in human testicular cancer cells[J].Eur J Cancer,1997,33(4):638-644.
  • 7[6]Kim NW,Piatyszek MA,Prowse KR,Harley CB,West MD,Ho PL,et al.Specific association of human telomerase activity with immortal cells and cancer[J].Science,1994,266(5193):2011-2015.
  • 8[7]Sumida T,Hamakawa H,Sogawa K,Sugita A,Tanioka H,Ueda N.Telomerase components as a diagnositic tool in human oral lesions[J].Int J Cancer,1999,80(1):1-48.
  • 9[8]Dieffenbach CW,Dveksler GS.PCR Primer: A Laboratory Manual[M].Translated by Huang PT,Yu WY,Chen TM,Wang JH,Wang X,Lu BS,et al.Beijing: Science Press,1999.206-217.
  • 10[9]Nakamura TM,Morin GB,Chapman KB,Weinerich SL,Andrews WH,Lingner J,et al.Telomerase catalytic subunit homologs from fission yeast and human[J].Science,1997,277(5328):955-959.

共引文献14

同被引文献19

  • 1刘浩,俞光岩.染料木黄酮抗涎腺腺样囊性癌远处转移的实验研究[J].中华口腔医学杂志,2004,39(5):373-375. 被引量:10
  • 2顾岩,陈积圣,周晓东,高劲松.Genistein抑制裸鼠肝癌移植瘤侵袭性生长[J].中华肝胆外科杂志,2005,11(3):184-187. 被引量:2
  • 3何景利,王贵英,单宝恩.三氧化二砷联合顺铂对人结肠癌细胞株colon26抑制作用机理的研究[J].中国肿瘤临床,2005,32(19):1125-1128. 被引量:5
  • 4胡晓文,黄洪章,谢谦.阿霉素作为G-四联体配体对Tca8113细胞影响的研究[J].中国口腔颌面外科杂志,2005,3(3):212-217. 被引量:3
  • 5金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 6Jones TH,Justice SK, Price A. Suppression of tyrosine kinase activity inhibits[3H] thymidine uptake in cultured human pituitary tumor cells [J]. Clin Endocrinol Metab, 1997,82(7) :2143 - 2147.
  • 7Tawfik MA, Elattar, Adi S. The inhibitory effect of curcumin, genisrein, quercetin and cisplantin on the growth of oral cancer cells in vitro [J]. Anticancer Res,2000,20(3A): 1733- 1738.
  • 8Ivaska J, Heino J. Adhesion receptors and cell invasion:mechanisms of integrim guided degradation of extracellular matrix[ J ]. Cell Mol Life Sci,2000,57(1) : 16 - 24.
  • 9Kumi-Diaka JK, Hassanhi M, Merchant K, et al. Influence of Genistein Isoflavone on Matrix Met alloproteinase-2 Expression in Prostate Cancer Cells[J] .J Med Food,2006,9(4):491 -497.
  • 10Xu L, Bergan RC. Genistein inhibits matrix met alloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway[ J]. Molecular Pharmacology, 2006,70(3) : 869 - 877.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部